Positive Results From A Trial Lift Adverum (ADVM) Stock Today

Pre-market trading saw a notable spike in the shares of Adverum Biotechnologies, Inc. (NASDAQ: ADVM). Adverum stock saw a 6.76% climb to $3.00, carrying on the momentum from the previous session when it experienced a 12.40% jump, finishing at $2.81. The excellent results of a clinical study are responsible for this rising trend and the […]

Market Globalist
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.